Antibacterial activity of head-to-head bis-benzimidazoles

Int J Antimicrob Agents. 2013 Oct;42(4):361-6. doi: 10.1016/j.ijantimicag.2013.04.033. Epub 2013 Jul 6.

Abstract

Symmetric bis-benzimidazole (BBZ) conjugates were profiled for activity against a range of Gram-positive and Gram-negative bacteria. para-Substituted ethoxy, amino and methoxy derivatives displayed potent bacteriostatic activity against meticillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, streptococci and Listeria monocytogenes. Moderate to good activity was also found against mycobacteria; two compounds were strongly active against logarithmic phase and hypoxia-induced latent Mycobacterium tuberculosis. No compound displayed significant activity towards Gram-negative bacteria. Only high concentrations of antibacterial BBZs showed cytotoxic effects towards fibroblasts, and the most active compound was well tolerated by zebrafish embryos.

Keywords: Antibacterial bis-benzimidazoles; Gram-positive pathogens; Mycobacterium tuberculosis; Staphylococcus aureus.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / chemical synthesis
  • Anti-Bacterial Agents / pharmacology*
  • Anti-Bacterial Agents / toxicity
  • Benzimidazoles / chemical synthesis
  • Benzimidazoles / pharmacology*
  • Benzimidazoles / toxicity
  • Cell Line
  • Cell Survival / drug effects
  • Fibroblasts / drug effects
  • Gram-Negative Bacteria / drug effects*
  • Gram-Positive Bacteria / drug effects*
  • Humans
  • Microbial Sensitivity Tests

Substances

  • Anti-Bacterial Agents
  • Benzimidazoles